 | • レポートコード：MRC2-11QY12377 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は炎症性心疾患のグローバル市場について調査・分析したレポートです。種類別（アテローム性動脈硬化症、心筋炎、心膜炎）市場規模、用途別（病院・診断センター、外来サービスセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別炎症性心疾患の競争状況、市場シェア ・世界の炎症性心疾患市場：種類別市場規模 2015年-2020年（アテローム性動脈硬化症、心筋炎、心膜炎） ・世界の炎症性心疾患市場：種類別市場規模予測 2021年-2026年（アテローム性動脈硬化症、心筋炎、心膜炎） ・世界の炎症性心疾患市場：用途別市場規模 2015年-2020年（病院・診断センター、外来サービスセンター） ・世界の炎症性心疾患市場：用途別市場規模予測 2021年-2026年（病院・診断センター、外来サービスセンター） ・北米の炎症性心疾患市場分析：米国、カナダ ・ヨーロッパの炎症性心疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの炎症性心疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の炎症性心疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの炎症性心疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Johnson & Johnson、Roche、Novartis、Pfizer、AstraZeneca、Merck、GSK、Bristol-Myers Squibb、Eli Lilly、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment.
Changing lifestyle resulting in higher prevalence of viral and fungal infection which is a one of the major factors motivating the growth of this market. In addition, increasing healthcare expenditure by government to confront rising prevalence of cardiovascular disease. Furthermore, Continuous improvement by leading market players in Inflammatory heart disease drug and development in online pharmacy has brought new opportunity to Inflammatory heart disease market.
Market Analysis and Insights: Global Inflammatory Heart Disease Market
The global Inflammatory Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Inflammatory Heart Disease Scope and Market Size
Inflammatory Heart Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Heart Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Johnson & Johnson
Roche
Novartis
Pfizer
AstraZeneca
Merck
GSK
Bristol-Myers Squibb
Eli Lilly
Sanofi
Market segment by Type, the product can be split into
Atherosclerosis
Myocarditis
Pericarditis
Market segment by Application, split into
Hospitals and Diagnostic Centers
Ambulatory Services Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Heart Disease Revenue
1.4 Market by Type
1.4.1 Global Inflammatory Heart Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Atherosclerosis
1.4.3 Myocarditis
1.4.4 Pericarditis
1.5 Market by Application
1.5.1 Global Inflammatory Heart Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Diagnostic Centers
1.5.3 Ambulatory Services Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Heart Disease Market Perspective (2015-2026)
2.2 Global Inflammatory Heart Disease Growth Trends by Regions
2.2.1 Inflammatory Heart Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Heart Disease Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Heart Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inflammatory Heart Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Inflammatory Heart Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Heart Disease Players by Market Size
3.1.1 Global Top Inflammatory Heart Disease Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Heart Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Inflammatory Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Heart Disease Market Concentration Ratio
3.2.1 Global Inflammatory Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Heart Disease Revenue in 2019
3.3 Inflammatory Heart Disease Key Players Head office and Area Served
3.4 Key Players Inflammatory Heart Disease Product Solution and Service
3.5 Date of Enter into Inflammatory Heart Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inflammatory Heart Disease Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Heart Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Inflammatory Heart Disease Market Size by Application (2015-2020)
5.2 Global Inflammatory Heart Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inflammatory Heart Disease Market Size (2015-2020)
6.2 Inflammatory Heart Disease Key Players in North America (2019-2020)
6.3 North America Inflammatory Heart Disease Market Size by Type (2015-2020)
6.4 North America Inflammatory Heart Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Inflammatory Heart Disease Market Size (2015-2020)
7.2 Inflammatory Heart Disease Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Heart Disease Market Size by Type (2015-2020)
7.4 Europe Inflammatory Heart Disease Market Size by Application (2015-2020)
8 China
8.1 China Inflammatory Heart Disease Market Size (2015-2020)
8.2 Inflammatory Heart Disease Key Players in China (2019-2020)
8.3 China Inflammatory Heart Disease Market Size by Type (2015-2020)
8.4 China Inflammatory Heart Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Inflammatory Heart Disease Market Size (2015-2020)
9.2 Inflammatory Heart Disease Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Heart Disease Market Size by Type (2015-2020)
9.4 Japan Inflammatory Heart Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Inflammatory Heart Disease Market Size (2015-2020)
10.2 Inflammatory Heart Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Heart Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Heart Disease Market Size by Application (2015-2020)
11 India
11.1 India Inflammatory Heart Disease Market Size (2015-2020)
11.2 Inflammatory Heart Disease Key Players in India (2019-2020)
11.3 India Inflammatory Heart Disease Market Size by Type (2015-2020)
11.4 India Inflammatory Heart Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Inflammatory Heart Disease Market Size (2015-2020)
12.2 Inflammatory Heart Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Heart Disease Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Heart Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Inflammatory Heart Disease Introduction
13.1.4 Abbott Revenue in Inflammatory Heart Disease Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Inflammatory Heart Disease Introduction
13.2.4 Johnson & Johnson Revenue in Inflammatory Heart Disease Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Inflammatory Heart Disease Introduction
13.3.4 Roche Revenue in Inflammatory Heart Disease Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Inflammatory Heart Disease Introduction
13.4.4 Novartis Revenue in Inflammatory Heart Disease Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Inflammatory Heart Disease Introduction
13.5.4 Pfizer Revenue in Inflammatory Heart Disease Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview
13.6.3 AstraZeneca Inflammatory Heart Disease Introduction
13.6.4 AstraZeneca Revenue in Inflammatory Heart Disease Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Inflammatory Heart Disease Introduction
13.7.4 Merck Revenue in Inflammatory Heart Disease Business (2015-2020)
13.7.5 Merck Recent Development
13.8 GSK
13.8.1 GSK Company Details
13.8.2 GSK Business Overview
13.8.3 GSK Inflammatory Heart Disease Introduction
13.8.4 GSK Revenue in Inflammatory Heart Disease Business (2015-2020)
13.8.5 GSK Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Inflammatory Heart Disease Introduction
13.9.4 Bristol-Myers Squibb Revenue in Inflammatory Heart Disease Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Inflammatory Heart Disease Introduction
13.10.4 Eli Lilly Revenue in Inflammatory Heart Disease Business (2015-2020)
13.10.5 Eli Lilly Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview
10.11.3 Sanofi Inflammatory Heart Disease Introduction
10.11.4 Sanofi Revenue in Inflammatory Heart Disease Business (2015-2020)
10.11.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Inflammatory Heart Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Inflammatory Heart Disease Revenue
Table 3. Ranking of Global Top Inflammatory Heart Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Inflammatory Heart Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Atherosclerosis
Table 6. Key Players of Myocarditis
Table 7. Key Players of Pericarditis
Table 8. Global Inflammatory Heart Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Inflammatory Heart Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Inflammatory Heart Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Inflammatory Heart Disease Market Share by Regions (2015-2020)
Table 12. Global Inflammatory Heart Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Inflammatory Heart Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Inflammatory Heart Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Inflammatory Heart Disease Players
Table 19. Global Inflammatory Heart Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Inflammatory Heart Disease Market Share by Players (2015-2020)
Table 21. Global Top Inflammatory Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Heart Disease as of 2019)
Table 22. Global Inflammatory Heart Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Inflammatory Heart Disease Product Solution and Service
Table 25. Date of Enter into Inflammatory Heart Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Inflammatory Heart Disease Market Size Share by Type (2015-2020)
Table 29. Global Inflammatory Heart Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Inflammatory Heart Disease Market Size Share by Application (2015-2020)
Table 31. Global Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Inflammatory Heart Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 35. North America Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 37. North America Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 41. Europe Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 43. Europe Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 45. China Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 47. China Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 49. China Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 53. Japan Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 55. Japan Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 59. Southeast Asia Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 63. India Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 65. India Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 67. India Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Inflammatory Heart Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Inflammatory Heart Disease Market Share (2019-2020)
Table 71. Central & South America Inflammatory Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Inflammatory Heart Disease Market Share by Type (2015-2020)
Table 73. Central & South America Inflammatory Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Inflammatory Heart Disease Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Product
Table 103. AstraZeneca Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 104. AstraZeneca Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Product
Table 108. Merck Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 109. Merck Recent Development
Table 110. GSK Business Overview
Table 111. GSK Product
Table 112. GSK Company Details
Table 113. GSK Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 114. GSK Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Product
Table 118. Bristol-Myers Squibb Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Product
Table 123. Eli Lilly Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 124. Eli Lilly Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Business Overview
Table 127. Sanofi Product
Table 128. Sanofi Revenue in Inflammatory Heart Disease Business (2015-2020) (Million US$)
Table 129. Sanofi Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Heart Disease Market Share by Type: 2020 VS 2026
Figure 2. Atherosclerosis Features
Figure 3. Myocarditis Features
Figure 4. Pericarditis Features
Figure 5. Global Inflammatory Heart Disease Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Diagnostic Centers Case Studies
Figure 7. Ambulatory Services Centers Case Studies
Figure 8. Inflammatory Heart Disease Report Years Considered
Figure 9. Global Inflammatory Heart Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Inflammatory Heart Disease Market Share by Regions: 2020 VS 2026
Figure 11. Global Inflammatory Heart Disease Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Inflammatory Heart Disease Market Share by Players in 2019
Figure 14. Global Top Inflammatory Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Heart Disease as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Inflammatory Heart Disease Revenue in 2019
Figure 16. North America Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Inflammatory Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
リウマチ性心臓病の世界市場（～2026年） Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged. Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expen…- 先天性心疾患の世界市場（～2026年） A congenital heart disease is a problem in the structure of the heart that is present at birth. The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number …
- 炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- 炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 虚血性心疾患（IHD）薬の世界市場（～2026年） Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…